Terms: = Uterine cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
532 results:
1. MUC1 promotes cervical squamous cell carcinoma through erk phosphorylation-mediated regulation of ITGA2/ITGA3.
Zhao A; Pan Y; Gao Y; Zhi Z; Lu H; Dong B; Zhang X; Wu M; Zhu F; Zhou S; Ma S
BMC Cancer; 2024 May; 24(1):559. PubMed ID: 38702644
[TBL] [Abstract] [Full Text] [Related]
2. Protective effect of quercetin on lipopolysaccharide‑induced miscarriage based on animal experiments and network pharmacology.
Wu S; Tian Y; Zhang Q; Fu Z; Lan H; Zhou X; Ma L; Lou Y
Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38606505
[TBL] [Abstract] [Full Text] [Related]
3. Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-erk Signaling Pathway in Endometrial cancer Cells.
Tian S; Ren L; Liu C; Wang Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474453
[TBL] [Abstract] [Full Text] [Related]
4. DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/erk pathway.
Xie S; Jin Y; Wang J; Li J; Peng M; Zhu X
BMC Cancer; 2024 Mar; 24(1):296. PubMed ID: 38438882
[TBL] [Abstract] [Full Text] [Related]
5. Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis.
Bian Z; Wu X; Chen Q; Gao Q; Xue X; Wang Y
Cancer Immunol Immunother; 2024 Mar; 73(4):73. PubMed ID: 38430256
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence of PD-L1 in Cervical cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
Bräutigam K; Schmidt T; Baur M; Tauber N; Kontomanolis EN; Hemptenmacher F; Rody A; Köster F
Anticancer Res; 2024 Feb; 44(2):503-510. PubMed ID: 38307554
[TBL] [Abstract] [Full Text] [Related]
7. Tumor cells-derived extracellular vesicles carry circ_0064516 competitively inhibit microRNA-6805-3p and promote cervical cancer angiogenesis and tumor growth.
Wang Y; Xie Y; Wang X; Yang N; Wu Z; Zhang X
Expert Opin Ther Targets; 2024; 28(1-2):97-112. PubMed ID: 38270096
[TBL] [Abstract] [Full Text] [Related]
8. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
10. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/erk MAPK signalling.
Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
[TBL] [Abstract] [Full Text] [Related]
11. [Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway].
Tian J; Wang N; Wang C; Wu DP; Wang CH; Ding XJ; Wang YK
Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):879-891. PubMed ID: 37875424
[No Abstract] [Full Text] [Related]
12. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
13. Alkaloids from
Wan Q; Xu J; Zhu C; Liu X; Tu Y; Lei J; Yu J
J Agric Food Chem; 2023 Jul; 71(27):10349-10360. PubMed ID: 37392181
[No Abstract] [Full Text] [Related]
14. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
15. E7050 Suppresses the Growth of Multidrug-Resistant Human uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
16. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/erk/TRIB3 pathway.
Zhang W; Liu M; Ji Y; Yu D; Ma C; Zhao J; Qu P
Arch Biochem Biophys; 2023 Jul; 743():109655. PubMed ID: 37285895
[TBL] [Abstract] [Full Text] [Related]
17. Integrating Spatial Transcriptomics and Single-nucleus RNA Sequencing Reveals the Potential Therapeutic Strategies for uterine Leiomyoma.
Wang J; Xu P; Zou G; Che X; Jiang X; Liu Y; Mao X; Zhang X
Int J Biol Sci; 2023; 19(8):2515-2530. PubMed ID: 37215998
[TBL] [Abstract] [Full Text] [Related]
18. Research advances in endometriosis-related signaling pathways: A review.
Zhang M; Xu T; Tong D; Li S; Yu X; Liu B; Jiang L; Liu K
Biomed Pharmacother; 2023 Aug; 164():114909. PubMed ID: 37210898
[TBL] [Abstract] [Full Text] [Related]
19. Localized Endometrial Proliferations of Pregnancy are Clonal Glandular Outgrowths Characterized by PTEN Loss and PIK3CA Pathogenic Variants.
Wepy C; Chapel DB; Mutter GL; Quade BJ; Nucci MR; Parra-Herran C
Mod Pathol; 2023 Aug; 36(8):100213. PubMed ID: 37172903
[TBL] [Abstract] [Full Text] [Related]
20. uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
Bai L; Chen Y; Han L; Zheng A; Mo X
BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
[TBL] [Abstract] [Full Text] [Related]
[Next]
